Related references
Note: Only part of the references are listed.Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned
Ismail Can et al.
EXPERIMENTAL HEMATOLOGY (2022)
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T
Julia Wiedmeier-Nutor et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
Ran Gao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Eμ-TCL1 mice
Bola S. Hanna et al.
HAEMATOLOGICA (2021)
Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy
Stefania Trino et al.
LEUKEMIA (2021)
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia
Michelle J. Cox et al.
MOLECULAR THERAPY (2021)
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
Elisavet Vlachonikola et al.
FRONTIERS IN IMMUNOLOGY (2021)
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
Riyao Yang et al.
NATURE COMMUNICATIONS (2021)
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Feiya Ma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia
Maria Montserrat Aguilar-Hernandez et al.
CURRENT ONCOLOGY REPORTS (2021)
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis
Martin Boettcher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Current Treatment Options in CLL
Moritz Bewarder et al.
CANCERS (2021)
Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
Veronika Mancikova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
Valentin Vautrot et al.
CANCERS (2021)
Signaling networks in immunometabolism
Jordy Saravia et al.
CELL RESEARCH (2020)
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean-Christophe Beltra et al.
IMMUNITY (2020)
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
Philipp M. Roessner et al.
LEUKEMIA (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
TIGIT in cancer immunotherapy
Joe-Marc Chauvin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles
Nathan Dubois et al.
FRONTIERS IN ONCOLOGY (2020)
SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution
Rafael J. Arguello et al.
CELL METABOLISM (2020)
Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
Valentina Griggio et al.
FRONTIERS IN IMMUNOLOGY (2020)
Metabolic and epigenetic regulation of T-cell exhaustion
Fabien Franco et al.
NATURE METABOLISM (2020)
Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL
Jordan Gauthier et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
The metabolic spectrum of memory T cells
David O'Sullivan
IMMUNOLOGY AND CELL BIOLOGY (2019)
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function
Julio C. Chavez et al.
BLOOD (2019)
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
Tiziana Vaisitti et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
Beatris Mastelic-Gavillet et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Anas Younes et al.
LANCET HAEMATOLOGY (2019)
Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway
Linsen Shi et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
Claudia Sorrentino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
Marina Wierz et al.
BLOOD (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
Jean-Marc Hoffmann et al.
FRONTIERS IN IMMUNOLOGY (2018)
D-2-hydroxyglutarate interferes with HIF-1 stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization
Martin Boettcher et al.
ONCOIMMUNOLOGY (2018)
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Ramon I. Klein Geltink et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Zijun Y. Xu-Monette et al.
BLOOD (2018)
Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells
Katrin S. Reiners et al.
HAEMATOLOGICA (2017)
CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D
H. Bruns et al.
LEUKEMIA (2017)
Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells
Katrin S. Reiners et al.
HAEMATOLOGICA (2017)
Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
Giovanni D'Arena et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Franziska Haderk et al.
SCIENCE IMMUNOLOGY (2017)
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Wei Ding et al.
BLOOD (2017)
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment
Elisa ten Hacken et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells
Dawn T. Smallwood et al.
BLOOD (2016)
Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake
Erik R. Abels et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
Jerome Paggetti et al.
BLOOD (2015)
PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
Fabienne McClanahan et al.
BLOOD (2015)
Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
Yuh-Ying Yeh et al.
BLOOD (2015)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
T cell metabolism drives immunity
Michael D. Buck et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Regina Jitschin et al.
BLOOD (2014)
Metabolic regulation of regulatory T cell development and function
David John Coe et al.
FRONTIERS IN IMMUNOLOGY (2014)
Routes and mechanisms of extracellular vesicle uptake
Laura Ann Mulcahy et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Regulation of immune responses by extracellular vesicles
Paul D. Robbins et al.
NATURE REVIEWS IMMUNOLOGY (2014)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
The who's who of T-cell differentiation: Human memory T-cell subsets
Yolanda D. Mahnke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Chronic Lymphocytic Leukemia Cells Are Activated and Proliferate in Response to Specific T Helper Cells
Audun Os et al.
CELL REPORTS (2013)
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
Alan G. Ramsay et al.
BLOOD (2012)
Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
Claudia Nunes et al.
CLINICAL CANCER RESEARCH (2012)
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2012)
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
Sara Serra et al.
BLOOD (2011)
Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia
Ana P. Gonzalez-Rodriguez et al.
LEUKEMIA & LYMPHOMA (2010)
Eμ-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction
Gullu Gorgun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G. Ramsay et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
TGF-β induces Foxp3+T-regulatory cells from CD4+CD25-precursors
S Fu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Abnormal T-cell function in B-cell chronic lymphocytic leukaemia
S Scrivener et al.
LEUKEMIA & LYMPHOMA (2003)
The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling
ML Dustin et al.
NATURE IMMUNOLOGY (2000)
Share Paper
